Cardiac SAEs · people who smoke
Varenicline showed no clear difference in cardiac SAEs (varenicline vs placebo or no medication) compared with placebo or no medication (low certainty).
1 finding from 1 review
Smoking abstinence at longest · people who smoke
Cytisine probably leads to higher smoking abstinence at longest compared with placebo or no medication (moderate certainty).
1 finding from 1 review
SAEs · people who smoke
Cytisine showed no clear difference in SAEs (cytisine vs placebo or no medication) compared with placebo or no medication (low certainty).
1 finding from 1 review
Neuropsychiatric SAEs · people who smoke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiac SAEs · people who smoke
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Smoking abstinence at longest · people who smoke
Cytisine showed no clear difference in smoking abstinence at longest compared with varenicline (low certainty).
1 finding from 1 review
Incidence of retinopathy at 4 to 5 years · type 1 or type 2 diabetics
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Progression of retinopathy · type 1 or type 2 diabetics
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Combined incidence and progression of diabetic retinopathy by 5 years · type 1 or type 2 diabetics
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Incidence of PDR/CSME/VH by 5 years · type 1 or type 2 diabetics
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Change in visual loss associated with PSR: visual loss is defined by the deterioration of visual acuity of 3 lines or more with the Snellen chart · type 1 or type 2 diabetics
It is very uncertain whether blood pressure intervention/intensive blood pressure intervention changes visual acuity (loss of 3 lines or more) by 5 years compared with placebo/standard blood pressure intervention (very low certainty).
1 finding from 1 review
Adverse events—all‐cause mortality · type 1 or type 2 diabetics
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Adverse events: hypotension · type 1 or type 2 diabetics
Blood pressure intervention/intensive blood pressure intervention may leads to higher adverse events—hypotension compared with placebo/standard blood pressure intervention (low certainty).
1 finding from 1 review
Viral respiratory illness ‐ influenza/COVID‐like illness · general population
Medical/surgical masks showed no clear difference in viral respiratory illness ‐ influenza/COVID‐like illness compared with no masks (moderate certainty).
1 finding from 1 review
Influenza assessed by laboratory confirmation · general population and healthcare workers
Hand hygiene showed no clear difference in laboratory‐confirmed influenza compared with control (low certainty).
1 finding from 1 review
Composite of acute respiratory illness, influenza‐like illness, laboratory‐confirmed influenza · general population and healthcare workers
Hand hygiene may leads to lower composite of acute respiratory illness, influenza‐like illness,… compared with control (low certainty).
1 finding from 1 review
Adverse events · general population and healthcare workers
1 finding from 1 review
Viral respiratory illness ‐ laboratory‐confirmed influenza/SARS‐CoV‐2 · general population
Medical/surgical masks showed no clear difference in viral respiratory illness ‐ laboratory‐confirmed influenza/SARS‐CoV‐2 compared with no masks (moderate certainty).
1 finding from 1 review
Adverse events · general population
1 finding from 1 review
Viral illness ‐ clinical respiratory illness · general population and healthcare workers
It is very uncertain whether N95 respirators changes viral respiratory illness ‐ clinical respiratory illness compared with medical/surgical masks (very low certainty).
1 finding from 1 review